Nexstim to present at Biotech Showcase 9th Annual Conference in San Francisco

Helsinki, Finland: 5 January 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, today announces that Chairman of the Board and Chief Executive Officer, Martin Jamieson, will be presenting at the 9th Annual Biotech Showcase Conference in San Francisco on Wednesday 11 January 2017 at 10:30am at Hilton San Francisco Union Square, Room 8, Ballroom Level.

Biotech ShowcaseTM is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. In addition to biopharmaceutical and life science company executives, Biotech Showcase delegates include investors in private and public companies, sector analysts, bankers and industry professionals.

More info on Nexstim's website


Next > Avantium acquires Liquid Light

Previous > NGDATA closes additional $9.4 million Series B Round for next generation Customer Experience Management